Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Restructuring Costs (2016 - 2018)

Fortress Biotech (FBIO) has 3 years of Restructuring Costs data on record, last reported at $1.7 million in Q3 2018.

  • For Q3 2018, Restructuring Costs fell 52.19% year-over-year to $1.7 million; the TTM value through Sep 2018 reached $7.3 million, down 3.91%, while the annual FY2017 figure was $8.8 million, 2696.19% up from the prior year.
  • Restructuring Costs reached $1.7 million in Q3 2018 per FBIO's latest filing, down from $2.3 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $3.6 million in Q3 2017 and bottomed at $315000.0 in Q4 2016.
  • Average Restructuring Costs over 3 years is $1.9 million, with a median of $1.8 million recorded in 2018.
  • Peak YoY movement for Restructuring Costs: soared 373.97% in 2017, then tumbled 52.19% in 2018.
  • A 3-year view of Restructuring Costs shows it stood at $315000.0 in 2016, then skyrocketed by 373.97% to $1.5 million in 2017, then rose by 15.61% to $1.7 million in 2018.
  • Per Business Quant database, its latest 3 readings for Restructuring Costs were $1.7 million in Q3 2018, $2.3 million in Q2 2018, and $1.8 million in Q1 2018.